As the leader of gene therapy, he or she is responsible for leading team and building up related scientific capabilities. This person must have extensive experience with adeno associated virus (AAV) vectors and recombinant AAV-mediated gene therapy and/or genome-editing. He/she is able to lead the AAV-mediated gene therapy and genome editing projects, with good understanding of advancement in gene therapeutics.
Equal Opportunity Employer Minorities/Women/Veterans/Disabled
Join our Talent Community so we can keep you informed about upcoming events and opportunities that match your interests.